THE CLINICAL AND SUBCLINICAL CHARACTERISTICS OF DIFFUSE SCLEROSING VARIANT OF PAPILLARY THYROID CARCINOMA IN VIETNAM NATIONAL CANCER HOSPITAL
Main Article Content
Abstract
Objective: To describe some clinical and paraclinical characteristics of the diffuse sclerosing variant (DSV) of papillary thyroid carcinoma (PTC) treated in Vietnam National Cancer Hospital. Patients and methods: A descriptive study was conducted on 50 patients diagnosed with DSV-PTC who underwent surgery in Vietnam National Cancer Hospital from January 2016 to October 2024. Results: The mean age was 32.5 ± 11.2 years; 36% of patients were younger than 30 years, with a range of 6–57 years; female-to-male ratio was 9:1. 70% of patients presented with clinical symptoms such as neck mass, cervical lymphadenopathy, or dysphagia, while 30% were diagnosed during routine examination. On ultrasound, 34% showed diffuse bilateral thyroid involvement; diffuse microcalcifications were seen in 76%, ill-defined margins in 86%; TIRADS 4 accounted for 44%, and TIRADS 5 for 56%. Bilateral thyroid lobe involvement was present in 52%; multiple tumors (≥2) in 54%; tumor size ≥4 cm or suspected invasion of strap muscles in 24%. Suspicious cervical lymph nodes were detected by ultrasound in 68%, unilateral in 40% and bilateral in 20%, with 66% loss of hilar structure and 22% calcification. All patients underwent fine-needle aspiration cytology before surgery, which was positive in 76% and atypical/suspicious in 24%. Conclusions: The diffuse sclerosing variant of papillary thyroid carcinoma is a rare subtype, characterized by earlier age at diagnosis, more prominent clinical and paraclinical findings, and a tendency for extrathyroidal invasion and lymph node metastasis at the time of diagnosis compared with other subtypes.
Article Details
Keywords
Diffuse sclerosing variant of papillary thyroid carcinoma, papillary thyroid carcinoma.
References
2. Vickery AL, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M. Papillary carcinoma. Semin Diagn Pathol. 1985;2(2):90-100.
3. Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 1989;63:908–911. - Tìm trên Google. Accessed March 10, 2024.
4. Sywak M, Pasieka JL, Ogilvie T. A review of thyroid cancer with intermediate differentiation. J Surg Oncol. 2004;86(1):44-54. doi:10.1002/ jso.20044
5. Malandrino P, Russo M, Regalbuto C, et al. Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis. Thyroid. 2016;26(9):1285-1292. doi:10.1089/thy. 2016.0168
6. Nguyễn Xuân Hậu (2019). Nghiên cứu giá trị sinh thiết hạch cửa trong bệnh ung thư tuyến giáp, Luận án Tiến sĩ, Trường Đại học Y Hà Nội.
7. Lê Văn Quảng, Nguyễn Bá Đức, and Nguyễn Quốc Bảo. “Nhận xét đặc điểm lâm sàng và các phương pháp điều trị ung thư tuyến giáp tại Bệnh viện K từ năm 1992-2000.” Tạp chí Y học,(431) (2002): 323-326. Tạp chí Y học,(431). Published online 2002:323-326.
8. Cavaco D, Martins AF, Cabrera R, Vilar H, Leite V. Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases. Eur Thyroid J. 2021;11(1):e210020. doi:10.1530/ETJ-21-0020